South Korea is confronting a deepening shortage of cephalosporins, a commonly prescribed class of antibiotics used to treat a range of bacterial infections, as pharmaceutical firms discontinue product lines due to unprofitability and growing raw materials costs. “As the number of local and overseas pharmaceutical companies have recently halted or downsized cephalosporins production here, it has become increasin...